Achieve Life Sciences, Inc. (ACHV) Ownership
ACHV ownership summary
as of October 17, 2026- Institutions
- 82.1% of shares outstanding
- Insiders
- 0.91% of shares outstanding
- Shares outstanding
- 103.1M
- Float
- 74.7M shares available to trade
- Short interest
- 17.08% 17.5M shares short
- Days to cover
- 10.47 short interest up 9.3% vs prior month
- Institutions 82.10%
- Insiders 0.91%
- Other investors 16.99%
ACHV top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 7.40% | 7.6M | $48.6M | +7.6M (0.0%) | June 30, 2026 |
| 2 | TPG GP A, LLC | 6.68% | 6.9M | $43.9M | +6.9M (0.0%) | June 30, 2026 |
| 3 | venBio Partners LLC | 5.75% | 5.9M | $37.7M | +5.9M (0.0%) | June 30, 2026 |
| 4 | Logos Global Management LP | 5.27% | 5.4M | $34.6M | +5.4M (0.0%) | June 30, 2026 |
| 5 | BlackRock Inc | 5.12% | 5.3M | $33.6M | +4.8M (+1,099.9%) | June 30, 2026 |
| 6 | Franklin Templeton Inc | 4.81% | 5.0M | $31.6M | +584,027 (+13.4%) | June 30, 2026 |
| 7 | Paradigm Biocapital Advisors LP | 4.81% | 5.0M | $31.6M | +5.0M (0.0%) | June 30, 2026 |
| 8 | Vanguard Capital Management, LLC | 4.02% | 4.1M | $26.4M | +1.9M (+87.8%) | June 30, 2026 |
| 9 | Propel Bio Management LLC | 3.92% | 4.0M | $25.7M | +247,593 (+6.5%) | June 30, 2026 |
| 10 | Marshall Wace Asset Management Ltd | 3.66% | 3.8M | $24.1M | +2.8M (+269.9%) | June 30, 2026 |
| 11 | State Street Corp | 2.86% | 2.9M | $18.8M | +2.7M (+1,057.6%) | June 30, 2026 |
| 12 | Vivo Capital, LLC | 2.67% | 2.8M | $17.6M | +2.8M (0.0%) | June 30, 2026 |
| 13 | VR Adviser, LLC | 2.67% | 2.8M | $17.6M | +2.8M (0.0%) | June 30, 2026 |
| 14 | Jupiter Topco LLC | 2.67% | 2.8M | $17.6M | +2.8M (0.0%) | June 30, 2026 |
| 15 | Eventide Asset Management, LLC | 2.16% | 2.2M | $14.2M | +2.2M (0.0%) | June 30, 2026 |
| 16 | Geode Capital Management, LLC | 2.00% | 2.1M | $13.2M | +1.4M (+231.2%) | June 30, 2026 |
| 17 | Alyeska Investment Group, L.P. | 1.87% | 1.9M | $12.3M | +1.9M (0.0%) | June 30, 2026 |
| 18 | Simplify Asset Management Inc. | 1.39% | 1.4M | $9.1M | +247,593 (+20.9%) | June 30, 2026 |
| 19 | Wellington Management Company LLP | 1.39% | 1.4M | $9.1M | +1.4M (0.0%) | June 30, 2026 |
| 20 | LPL Financial Corp | 0.88% | 902K | $5.8M | +173,807 (+23.9%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 20 holders added 59.5M shares and 0 cut 0.
ACHV top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.02% | 3.1M | $19.8M | — | August 31, 2026 |
| 2 | Eventide Healthcare & Life Sciences I | 2.16% | 2.2M | $14.2M | +2.2M (0.0%) | June 30, 2026 |
| 3 | State Street® SPDR® S&P® Biotech ETF | 2.05% | 2.1M | $13.5M | −40,300 (−1.9%) | September 30, 2026 |
| 4 | iShares Russell 2000 ETF | 1.98% | 2.0M | $13.0M | −23,424 (−1.1%) | September 30, 2026 |
| 5 | Franklin Biotechnology Discv A(acc)USD | 1.88% | 1.9M | $12.3M | — | August 31, 2026 |
| 6 | Franklin Biotechnology Discovery A | 1.06% | 1.1M | $7.0M | — | August 31, 2026 |
| 7 | Simplify Propel Opportunities ETF | 0.91% | 932K | $5.9M | — | September 30, 2026 |
| 8 | Fidelity Small Cap Index | 0.83% | 852K | $5.4M | +7,297 (+0.9%) | July 31, 2026 |
| 9 | iShares Russell 2000 Growth ETF | 0.70% | 718K | $4.6M | −909 (−0.1%) | September 30, 2026 |
| 10 | Vanguard Russell 2000 ETF | 0.43% | 447K | $2.9M | +10,426 (+2.4%) | August 31, 2026 |
| 11 | Fidelity Extended Market Index | 0.40% | 407K | $2.6M | −5,613 (−1.4%) | August 31, 2026 |
| 12 | Fidelity Enhanced Small Cap Core ETF | 0.30% | 310K | $2.0M | +648 (+0.2%) | September 30, 2026 |
| 13 | BNY Mellon Sm/Md Cp Gr I | 0.26% | 263K | $1.7M | +263,270 (0.0%) | August 31, 2026 |
| 14 | iShares Micro-Cap ETF | 0.24% | 245K | $1.6M | −1,692 (−0.7%) | September 30, 2026 |
| 15 | Schwab Small Cap Index | 0.18% | 189K | $1.2M | — | August 31, 2026 |
| 16 | Fidelity Total Market Index | 0.17% | 170K | $1.1M | — | August 31, 2026 |
| 17 | iShares Russell 2000 Small-Cap Idx Instl | 0.14% | 146K | $928,335 | — | August 31, 2026 |
| 18 | iShares Core S&P Total US Stock Mkt ETF | 0.14% | 144K | $918,037 | +120 (+0.1%) | September 30, 2026 |
| 19 | Fidelity Series Total Market Index | 0.12% | 128K | $818,924 | −5,959 (−4.4%) | August 31, 2026 |
| 20 | Stt Strt SPDR® Russell2000 US SmCapETF | 0.12% | 127K | $812,965 | +6,100 (+5.0%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ACHV insider transactions
latest 6| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-18 | Mark K Oki | Sell | $2.92 | 50,060 | $146,175 |
| 2025-09-18 | Richard Alistair Stewart | Sell | $2.92 | 129,501 | $378,143 |
| 2025-09-04 | Cindy Jacobs | Sell | $2.77 | 27,629 | $76,532 |
| 2025-09-04 | Jaime Xinos | Sell | $2.77 | 20,854 | $57,766 |
| 2025-09-04 | Jerry Wan | Sell | $2.77 | 14,070 | $38,974 |
| 2025-09-04 | Thomas Braxton King | Sell | $2.77 | 139,858 | $387,407 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ACHV shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ACHV
Institutional investors own 82.1% of Achieve Life Sciences's shares and insiders 0.91%. The largest holder is Frazier Life Sciences Management, L.P. with 7.40% of the shares (7.6M), as of June 30, 2026. Among the top 20 institutions, 20 added shares and 0 reduced their stake in the latest filings. Short interest is 17.08% of the float, or 10.47 days of average trading volume. The share count rose 543,536.7% since 2014.
Related: ACHV analyst forecast, ACHV key metrics. See the ACHV stock overview for the latest quote and news.
ACHV ownership FAQ
Who owns the most Achieve Life Sciences stock?
The largest shareholders of Achieve Life Sciences are Frazier Life Sciences Management, L.P. (7.40%), TPG GP A, LLC (6.68%), venBio Partners LLC (5.75%), Logos Global Management LP (5.27%), BlackRock Inc (5.12%).
What percentage of Achieve Life Sciences is owned by institutions?
Institutions hold 82.1% of Achieve Life Sciences's shares outstanding; insiders hold 0.91%.
Which funds own Achieve Life Sciences?
The largest fund holders of Achieve Life Sciences are Vanguard MStar Total Stk Mkt Idx Invest (3.02%), Eventide Healthcare & Life Sciences I (2.16%), State Street® SPDR® S&P® Biotech ETF (2.05%), iShares Russell 2000 ETF (1.98%), Franklin Biotechnology Discv A(acc)USD (1.88%).
What is Achieve Life Sciences's short interest?
17.5M shares of Achieve Life Sciences were sold short, 17.08% of the float; at the average daily volume it would take 10.47 days to cover.
Are insiders buying or selling Achieve Life Sciences?
Of the latest 6 reported insider transactions in Achieve Life Sciences (since September 4, 2025), 0 were purchases and 6 were sales.
How many shares of Achieve Life Sciences are outstanding?
Achieve Life Sciences has 103.1M shares outstanding, of which 74.7M are in the public float.